Cargando…

Tumor mutation burden and recurrent tumors in hereditary lung cancer

Lung cancer is the leading cause of cancer death worldwide and cancer relapse accounts for the majority of cancer mortality. The mechanism is still unknown, especially in hereditary lung cancer without known actionable mutations. To identify genetic alternations involved in hereditary lung cancer an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsu, Yi‐Chiung, Chang, Ya‐Hsuan, Chang, Gee‐Chen, Ho, Bing‐Ching, Yuan, Shin‐Sheng, Li, Yu‐Cheng, Zeng, Jhih‐Wun, Yu, Sung‐Liang, Li, Ker‐Chau, Yang, Pan‐Chyr, Chen, Hsuan‐Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536970/ https://www.ncbi.nlm.nih.gov/pubmed/30941903 http://dx.doi.org/10.1002/cam4.2120

Ejemplares similares

EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
por: Chen, Hsuan-Yu, et al.
Publicado: (2016)

Genome-wide analysis of three-way interplay among gene expression, cancer cell invasion and anti-cancer compound sensitivity
por: Hsu, Yi-Chiung, et al.
Publicado: (2013)

ePIANNO: ePIgenomics ANNOtation tool
por: Liu, Chia-Hsin, et al.
Publicado: (2016)

The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma
por: Hung, Pei-Fang, et al.
Publicado: (2013)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma
por: Raghav, Lovely, et al.
Publicado: (2020)

Pathway-based gene signatures predicting clinical outcome of lung adenocarcinoma
por: Chang, Ya-Hsuan, et al.
Publicado: (2015)

Molecular gene signature and prognosis of non-small cell lung cancer
por: Huang, Poyin, et al.
Publicado: (2016)

Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death
por: Hieronymus, Haley, et al.
Publicado: (2018)

Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden
por: Kang, Nai-Wen, et al.
Publicado: (2021)

Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
por: Lee, Pei-Jung, et al.
Publicado: (2021)

MITF functions as a tumor suppressor in non-small cell lung cancer beyond the canonically oncogenic role
por: Hsiao, Yi-Jing, et al.
Publicado: (2020)

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening
por: Cremin, Carol, et al.
Publicado: (2020)

The clinicopathological significance of NAB2‐STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors
por: Huang, Shih‐Chiang, et al.
Publicado: (2015)

Antimetabolite pemetrexed primes a favorable tumor microenvironment for immune checkpoint blockade therapy
por: Lu, Chia-Sing, et al.
Publicado: (2020)

PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer
por: Zhang, Min, et al.
Publicado: (2020)

Photonic hyperthermia of malignant peripheral nerve sheath tumors at the third near-infrared biowindow
por: Gu, Yihui, et al.
Publicado: (2022)

The Tumor Immune Microenvironment Architecture Correlates with Risk of Recurrence in Head and Neck Squamous Cell Carcinoma
por: Weed, Donald T., et al.
Publicado: (2023)

A targeted next‐generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice
por: Lin, Po‐Han, et al.
Publicado: (2017)

The Prognostic Significance of PD1 and PDL1 Gene Expression in Lung Cancer: A Meta-Analysis
por: Chang, Chih-Hao, et al.
Publicado: (2021)

Prognostic value of miR-142 in solid tumors: a meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2021)

Truncation of GalNAc-type O-glycans Suppresses CD44-mediated Osteoclastogenesis and Bone Metastasis in Breast Cancer
por: Lin, Neng-Yu, et al.
Publicado: (2023)

Targetting an LncRNA P5848-ENO1 axis inhibits tumor growth in hepatocellular carcinoma
por: Zhu, Xidan, et al.
Publicado: (2019)

Enhancement of tumor lethality of ROS in photodynamic therapy
por: Ming, Lan, et al.
Publicado: (2020)

Proton pump inhibitors and risk of periampullary cancers—A nested case–control study
por: Chien, Li‐Nien, et al.
Publicado: (2015)

The anti-tumor effects of the combination of microwave hyperthermia and lobaplatin against breast cancer cells in vitro and in vivo
por: Li, Xiaohu, et al.
Publicado: (2022)

SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma
por: Hsiao, Yi-Jing, et al.
Publicado: (2016)

CD44‐associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage
por: Liu, Wei‐Hsiu, et al.
Publicado: (2019)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

Relationship between pretreatment concentration of plasma Epstein‐Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation
por: Peng, Liang, et al.
Publicado: (2018)

EZH2/hSULF1 axis mediates receptor tyrosine kinase signaling to shape cartilage tumor progression
por: Lin, Zong-Shin, et al.
Publicado: (2023)

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
por: Shi, Ji‐Hua, et al.
Publicado: (2019)

Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection
por: Hsu, Chia‐Chang, et al.
Publicado: (2019)

Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantation
por: Chuang, Yi-Hsuan, et al.
Publicado: (2019)

Global Burden of Cancer
por: Ma, Xiaomei, et al.
Publicado: (2007)

The extracts of Astragalus membranaceus overcome tumor immune tolerance by inhibition of tumor programmed cell death protein ligand-1 expression
por: Chang, Hsu-Liang, et al.
Publicado: (2020)

Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer
por: Su, Wei-Chih, et al.
Publicado: (2021)

Tumor‐driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL‐8
por: Chen, Shao‐jie, et al.
Publicado: (2018)

Outcomes for Atypical Tumor Recurrences Following Minimally Invasive Kidney Cancer Operations
por: Russo, Paul, et al.
Publicado: (2022)

Reduced symmetric dimethylation stabilizes vimentin and promotes metastasis in MTAP‐deficient lung cancer
por: Chang, Wen‐Hsin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cv5kc6ftlqd9hon1qko8s7fuqu